Olmsted Syndrome
Olmsted syndrome is a rare genetic condition that primarily affects the skin, leading to thickened skin on the palms and soles, as well as hair loss. It can also cause other skin abnormalities.
Olmsted Syndrome: KM-023 Treatment Study
We are testing a new treatment called KM-023 in healthy volunteers and patients with Olmsted syndrome. The goal is to learn about its safety and how it may help those affected by this condition.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Hopital Saint Louis
Service de dermatologie
Quinze-Vingts, France
Biotrial
Unité Clinique
Rennes, France
Sponsor: Kamari Pharma Ltd.
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.